Skip to main content
Trusted advisor to healthcare practitioners · Est. 2016

Biologics · For physicians

Combining PRP and Shockwave Therapy for Chronic Tendinopathy

Published November 17, 2026

Primary Biological Mechanisms
Mechanotransduction + Cytokine Delivery

ECSWT provides physical acoustic stimulus to upregulate local vascularity, while PRP supplies concentrated autologous growth factors.

Typical Treatment Cadence
1–2 PRP Injections + Multi-Session ECSWT

Protocols generally pair a single or dual biologic injection with a structured series of weekly shockwave applications.

Practice Cost Structure
Capital Equipment + Per-Kit Consumables

Combines the high-margin, low-consumable model of an acoustic wave device with single-use sterile PRP preparation kits.

Combining PRP and shockwave therapy for chronic tendinopathy provides a dual-phase regenerative protocol where acoustic wave pre-conditioning optimizes local tissue perfusion prior to targeted autologous growth factor injection. By pairing advanced devices with concentrated biologics, clinical teams can address the severe hypovascularity and matrix breakdown that frequently cause monotherapy interventions to stall. Below, we detail evidence-based treatment intervals, energy dosing parameters, and practical workflow considerations for outpatient regenerative practices.

The Pathophysiology of Chronic Tendinopathy

When evaluating treatment failures in chronic tendinopathy—whether affecting the Achilles, patellar, lateral epicondyle, or rotator cuff tendons—clinicians are rarely dealing with an active inflammatory process. Instead, histopathology typically reveals angiofibroblastic hyperplasia: disorganized type III collagen fibers, mucoid degeneration, tenocyte apoptosis, and poorly organized neovessels lacking functional perfusion.

Because chronic tendinosis represents a stalled healing cascade rather than acute inflammation, traditional anti-inflammatory modalities like corticosteroid injections often provide only transient pain relief while potentially weakening the structural integrity of the tendon over time. Restoring functional load-bearing capacity requires restarting the endogenous repair cycle within a hypovascular, metabolically sluggish tissue environment. This clinical reality is the primary driver behind multimodal orthopedic regenerative protocols.

Dual Mechanisms: Why Acoustic Waves and Autologous Biologics Synergize

Using a single regenerative modality is often sufficient for mild-to-moderate tendon pathology. However, in long-standing, calcific, or severely degenerated cases, combining mechanical and biological stimuli addresses multiple bottlenecks in the healing cascade simultaneously.

Extracorporeal Shockwave Therapy (ECSWT)

Acoustic pressure waves delivered via regenerative shockwave devices interact with deep tissue through mechanotransduction. As the high-energy acoustic wave passes through the tendon matrix, the physical forces create controlled micro-cavitation and shear stress on tenocyte cell membranes. This mechanical stimulus triggers several biological responses:

  • Neovascularization: Upregulation of endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) at the bone-tendon junction, improving local microvascular blood supply.
  • Matrix Remodeling: Stimulation of tenocytes to shift from producing weaker type III collagen toward aligned type I collagen.
  • Nociceptive Modulation: Hyperstimulation analgesia and depletion of Substance P within the peritendinous tissue, helping to reduce pain sensitivity and facilitate earlier participation in eccentric loading programs.
  • Calcific Disruption: In calcific tendinopathies, the acoustic impedance mismatch helps fragment disorganized calcium deposits for macrophage clearance.

Platelet-Rich Plasma (PRP)

While shockwave therapy alters the physical microenvironment and signals local cells to wake up, autologous biologics like PRP deliver the raw signaling molecules required for sustained tissue synthesis. When platelets are concentrated via centrifugation and introduced into the lesion under ultrasound guidance, alpha-granules degranulate to release PDGF, TGF-beta, VEGF, and IGF-1.

These growth factors bind to receptors on the newly mechano-sensitized tenocytes and local mesenchymal stem cells, amplifying chemotaxis, cellular proliferation, and extracellular matrix deposition. In essence, ECSWT primes the soil and increases local vascular access, while PRP supplies concentrated biological fertilizer.

Clinical Comparison and Sequencing Considerations

Physicians integrating both modalities must decide whether to deploy them sequentially or concurrently, based on ultrasound findings, patient scheduling, and tissue reactivity.

  • Primary Stimulus: ECSWT provides an extrinsic physical force (mechanotransduction), whereas PRP provides an intrinsic biochemical signal (growth factor degranulation).
  • Anesthesia Requirements: ECSWT generally requires no local anesthesia (which can actually inhibit the neurogenic response of the acoustic wave), while PRP injections typically require local anesthetic at the skin and subcutaneous portal, avoiding direct intratendinous lidocaine or bupivacaine due to tenotoxicity and platelet inhibition.
  • Sequencing Option A (Pre-Conditioning with ECSWT): Many clinicians perform a short series of weekly shockwave sessions prior to the PRP injection. The rationale is to break up fibrotic tissue, stimulate early microvascular ingrowth, and upregulate cell surface receptors before introducing the platelet concentrate.
  • Sequencing Option B (PRP Followed by Delayed ECSWT): Alternatively, clinicians may perform the ultrasound-guided PRP injection first to initiate the acute inflammatory and proliferative phase. Once the initial post-injection flare subsides and early matrix deposition begins, shockwave therapy is introduced during the remodeling phase to encourage collagen fiber alignment along lines of stress.
  • Same-Day Protocols: Some practices apply shockwave therapy immediately prior to the PRP injection during the same visit to induce local hyperemia and potentially accelerate platelet activation in vivo, though care must be taken to manage patient comfort.

Clinical Evaluation Checklist for Multimodal Candidates

Not every patient presenting with tendon pain requires a combined protocol. Clinicians working in sports medicine practices and orthopedic clinics generally reserve dual therapy for specific clinical presentations:

  • Duration and Refractory Nature: Symptoms persisting for several months despite structured eccentric physical therapy and activity modification.
  • Diagnostic Imaging: Ultrasound or MRI confirmation of focal tendinosis, intrasubstance partial tearing, or calcific deposits, rather than complete full-thickness ruptures requiring surgical repair.
  • Systemic Readiness: Absence of active infection, severe thrombocytopenia, or anticoagulant therapy that cannot be safely held for an intratendinous injection.
  • Medication Clearance: Ability of the patient to discontinue non-steroidal anti-inflammatory drugs (NSAIDs) prior to and following the PRP phase to avoid blunting the cyclooxygenase pathway essential for platelet signaling.
  • Rehabilitation Commitment: Patient willingness to adhere to post-procedure load management and progressive physical therapy, as biological and mechanical stimuli require functional loading to guide collagen alignment.

Operational Workflow and Procurement for Practice Managers

For the practice manager or clinical director, offering a combined PRP and shockwave protocol requires distinct operational workflows that balance capital equipment utilization with single-use consumable management.

From a procurement perspective, the two modalities have contrasting cost structures. An ECSWT system represents a primary capital equipment acquisition with minimal per-treatment consumable costs (typically limited to acoustic coupling gel and periodic handpiece transmitter maintenance). Conversely, PRP carries a fixed per-procedure consumable cost driven by FDA-cleared concentration kits, blood draw supplies, and sterile ultrasound probe covers.

Bundling these modalities into a cohesive tendinopathy care pathway allows the practice to maximize the utilization rate of the shockwave device while maintaining healthy margins on the biologic procedure. Operationally, shockwave sessions are brief and can often be delegated to trained clinical support staff under physician supervision (depending on state scope-of-practice regulations and whether radial pressure wave or focused shockwave is utilized), freeing the physician's schedule for the diagnostic ultrasound and guided PRP injection.

What This Means for Your Practice

If your clinic is evaluating the addition of combined regenerative protocols for chronic musculoskeletal conditions, consider the following implementation steps:

  1. Audit Current Tendinopathy Volume: Review how many patients currently cycle through repeat corticosteroid injections or stall in physical therapy without progressing to surgery.
  2. Evaluate Centrifugation Consistency: Ensure your current PRP system reliably produces the desired platelet concentration and leukocyte profile (typically leukocyte-poor to moderate for intra-articular use, and tailored leukocyte content for chronic tendinopathies depending on clinical preference).
  3. Assess Acoustic Wave Technology: Distinguish between radial pressure wave devices (suited for superficial tendons and myofascial chains) and focused shockwave systems (capable of targeting deeper insertions and calcifications with higher energy flux density).
  4. Standardize Rehabilitation Hand-offs: Build clear post-procedure protocols with your internal or referring physical therapists so they understand when to restrict loading post-PRP and when to reintroduce eccentric training alongside ECSWT.

To evaluate clinical device specifications, compare autologous biologic preparation systems, or discuss service-line integration for your clinic, contact our team to schedule a practice consultation.

Frequently asked questions

Should shockwave therapy be performed before or after a PRP injection?
Clinical protocols vary depending on the pathology and physician preference. Many clinicians prefer to perform a series of shockwave sessions prior to the PRP injection to induce neovascularization and break down fibrotic tissue, priming the tendon matrix. Others administer the PRP injection first and introduce shockwave therapy a few weeks later during the tissue remodeling phase to stimulate tenocyte mechanotransduction and collagen alignment.
Can ECSWT and PRP be performed on the same day?
Yes, some protocols apply shockwave therapy immediately before the PRP injection during the same clinical visit. Applying acoustic waves first avoids dispersing the freshly injected fluid bolus and may help stimulate local hyperemia and in vivo platelet activation. However, clinicians must carefully evaluate tissue sensitivity and patient comfort when combining both stimuli in a single appointment.
Why must patients avoid NSAIDs during a combined PRP and shockwave protocol?
Non-steroidal anti-inflammatory drugs inhibit cyclooxygenase enzymes, which impairs platelet aggregation and blocks the release of essential growth factors from alpha-granules. Similarly, shockwave therapy relies on a controlled pro-inflammatory and neurogenic signaling cascade to initiate tissue remodeling. Using NSAIDs around the time of treatment blunts the biological efficacy of both modalities.
What types of chronic tendinopathy respond best to dual therapy?
Combined protocols are most commonly evaluated for recalcitrant conditions with poor baseline vascularity or high mechanical load requirements. Typical indications include chronic mid-substance or insertional Achilles tendinopathy, patellar tendinosis (jumper's knee), proximal hamstring tendinopathy, lateral epicondylitis, and partial-thickness rotator cuff tendinopathy.
How does combining PRP and shockwave affect practice workflow?
A combined protocol blends a single physician-intensive procedure (ultrasound-guided PRP draw and injection) with a series of brief, repeatable device visits (ECSWT). This structure optimizes room turnover and allows trained clinical staff to assist with blood processing and longitudinal shockwave sessions within state scope-of-practice guidelines.

Bring regenerative medicine into your practice.

Talk with our team about biologics, devices, or an AI-powered peptide protocol tailored to your patients.

Request Consultation →